Z. Lin et al. / Tetrahedron Letters 52 (2011) 4967–4970
4969
To summarize, the efficient copper(I)-catalyzed three-compo-
nent coupling reaction of alkynes, benzal dihalides and amines
through C–H and C-halogen activation to form propargylic amines
under mild conditions has been explored. These reactions offer an
alternative procedure for the synthesis of propargylic amines.
(m, 3H, Ar-H), 5.04 (s, 1H, CH), 2.59–2.68 (m, 2H, CH2), 2.48–2.57
(m, 2H, CH2), 1.08 (t, J = 7.2 Hz, 6H, CH3); 13C NMR (100 MHz,
CDCl3): d = 139.49, 133.93, 132.97, 128.56, 128.26, 128.04,
127.30, 121.76, 87.15, 86.27, 56.88, 44.46, 13.48; GC–MS: m/z:
297; HRMS (EI) calcd for C19H20Cl1N1 (M)+: 297.1284, found
297.1289.
Typical procedure for the production of propargyl amines
(Table 2, entry 1)
N,N-Diethyl-3-(4-methoxyphenyl)-1-phenylprop-2-yn-1-amine
(8B)
A mixture of tert-butylacetylene (1.0 mmol, 82 mg), benzal bro-
mide (1.5 mmol, 250 mg), diethylamine (2.0 mmol, 146 mg), Et3N
(1.0 mmol, 101 mg) and CuCl (10.0 mg, 10.0 mol %) were loaded
in a sealed reaction vial (10 mL) with 2 mL of CH3CN. After stirring
at room temperature for 36 h, the reaction mixture was diluted
with H2O (20 mL), extracted with Et2O (2 Â 10 mL), dried over
Na2SO4 and concentrated to give the crude product which was fur-
ther purified by column chromatography on silica gel (CH2Cl2) to
afford the corresponding propargyl amine. All products gave satis-
factory spectroscopic data.
1H NMR (400 MHz, CDCl3): d = 7.69 (d, J = 8.0 Hz, 2H, Ar-H), 7.45
(d, J = 8.0 Hz, 2H, Ar-H), 7.36 (t, J = 8.0 Hz, 2H, Ar-H), 7.28 (t,
J = 8.0 Hz, 1H, Ar-H), 6.87 (d, J = 8.0 Hz, 2H, Ar-H), 5.05 (s, 1H,
CH), 3.83 (s, 3H, CH3), 2.59–2.68 (m, 2H, CH2), 2.50–2.59 (m, 2H,
CH2), 1.08 (t, J = 7.2 Hz, 6H, CH3) 13C NMR (100 MHz, CDCl3):
d = 159.38, 140.06, 133.17, 128.40, 128.01, 127.20, 115.54,
113.69, 87.20, 84.47, 56.97, 55.33, 44.53, 13.59; GC–MS: m/z:
293; HRMS (EI) calcd for C20H23N1O1 (M)+: 293.1780, found
293.1788.
N,N-Diethyl-1-phenyl-3-p-tolylprop-2-yn-1-amine (10B)
N,N-Diethyl-4,4-dimethyl-1-phenylpent-2-yn-1-amine (1B)
1H NMR (400 MHz, CDCl3): d = 7.69 (d, J = 7.6 Hz, 2H, Ar-H), 7.40
(d, J = 7.6 Hz, 2H, Ar-H), 7.35 (t, J = 7.6 Hz, 2H, Ar-H), 7.28 (t,
J = 7.6 Hz, 1H, Ar-H), 7.14 (d, J = 7.6 Hz, 2H, Ar-H), 5.05 (s, 1H,
CH), 2.60–2.69 (m, 2H, CH2), 2.50–2.59 (m, 2H, CH2), 2.36 (s, 3H,
CH3), 1.08 (t, J = 7.2 Hz, 6H, CH3); 13C NMR (100 MHz, CDCl3):
d = 138.11, 131.67, 129.04, 128.42, 128.03, 127.26, 120.26, 99.99,
87.57, 85.18, 56.97, 44.55, 21.49, 13.52; GC–MS: m/z: 277; HRMS
(EI) calcd for C20H23N1 (M)+: 277.1830, found 277.1839.
1H NMR (400 MHz, CDCl3): d = 7.61 (d, J = 7.6 Hz, 2H, Ar-H), 7.32
(t, J = 7.6 Hz, 2H, Ar-H), 7.24 (t, J = 7.6 Hz, 1H, Ar-H), 4.78 (s, 1H,
CH), 2.48–2.55 (m, 2H, CH2), 2.37–2.45 (m, 2H, CH2), 1.30 (s, 9H,
CH3), 1.03 (t, J = 6.8 Hz, 6H, CH3); 13C NMR (100 MHz, CDCl3):
d = 140.61, 128.36, 127.81, 126.92, 96.31, 74.05, 56.21, 44.32,
31.44, 27.67, 13.57; GC–MS: m/z: 243; HRMS (ESI) calcd for
C
17H26N1 (M+H)+: 244.2060, found 244.2065.
N,N-Diethyl-1-phenylhept-2-yn-1-amine (2B)
1-(4,4-Dimethyl-1-phenylpent-2-ynyl)pyrrolidine (14B)
1H NMR (400 MHz, CDCl3): d = 7.61 (d, J = 7.2 Hz, 2H, Ar-H), 7.32
(t, J = 7.2 Hz, 2H, Ar-H), 7.25 (t, J = 7.2 Hz, 1H, Ar-H), 4.80 (s, 1H,
CH), 2.49–2.59 (m, 2H, CH2), 2.39–2.47 (m, 2H, CH2), 2.32 (dt,
J = 7.2 Hz, J = 2.0 Hz, 2H, CH2), 1.52–1.60 (m, 2H, CH2), 1.43–1.50
(m, 2H, CH2), 1.03 (t, J = 7.2 Hz, 6H, CH3), 0.94 (t, J = 7.2 Hz, 3H,
CH3); 13C NMR (100 MHz, CDCl3): d = 140.51, 128.37, 127.86,
126.99, 87.48, 75.88, 56.42, 44.38, 31.25, 22.02, 18.50, 13.67; GC–
MS: m/z: 243; HRMS (ESI) calcd for C17H26N1 (M+H)+: 244.2060,
found 244.2064.
1H NMR (400 MHz, CDCl3): d = 7.52 (d, J = 7.2 Hz, 2H, Ar-H), 7.32
(t, J = 7.2 Hz, 2H, Ar-H), 7.26 (t, J = 7.2 Hz, 1H, Ar-H), 4.61 (s, 1H,
CH), 2.57 (t, 4H, J = 6.8 Hz, CH2), 1.75 (t, J = 6.8 Hz, 4H, CH2), 1.27
(s, 9H, CH3); 13C NMR (100 MHz, CDCl3): d = 140.15, 128.31,
128.08, 127.30, 95.77, 75.04, 58.49, 49.99, 31.34, 27.61, 23.44;
GC–MS: m/z: 241; HRMS (EI) calcd for C17H23N1 (M)+: 241.1830,
found 241.1832.
1-(4,4-Dimethyl-1-phenylpent-2-ynyl)piperidine (15B)19
7-(Diethylamino)-7-phenylhept-5-ynenitrile (3B)
1H NMR (400 MHz, CDCl3): d = 7.55 (d, J = 7.6 Hz, 2H, Ar-H), 7.33
(t, J = 7.6 Hz, 2H, Ar-H), 7.26 (t, J = 7.6 Hz, 1H, Ar-H), 4.54 (s, 1H,
CH), 2.43 (t, J = 6.0 Hz, 4H, CH2), 1.56 (quin, J = 6.0 Hz, 4H, CH2),
1.40 (quin, J = 6.0 Hz, 2H, CH2), 1.30 (s, 9H, CH3); 13C NMR
(100 MHz, CDCl3): d = 139.29, 128.61, 127.89, 127.16, 96.82,
74.28, 61.73, 53.29, 31.55, 27.70, 26.21, 24.59; GC–MS: m/z: 255.
1H NMR (400 MHz, CDCl3): d = 7.57 (d, J = 7.2 Hz, 2H, Ar-H), 7.33
(t, J = 7.2 Hz, 2H, Ar-H), 7.26 (t, J = 7.2 Hz, 1H, Ar-H), 4.81 (s, 1H,
CH), 2.50–2.58 (m, 6H, CH2), 2.37–2.45 (m, 2H, CH2), 1.93(q,
J = 6.8 Hz, 2H, CH2), 1.03 (t, J = 7.2 Hz, 6H, CH3) 13C NMR
(100 MHz, CDCl3): d = 139.91, 128.20, 128.01, 127.23, 119.24,
84.30, 78.34, 56.41, 44.45, 24.96, 18.00, 16.25, 13.53, GC–MS: m/
z: 254; HRMS (EI) calcd for C17H22N2 (M+H)+: 254.1783, found
254.1792.
Acknowledgments
This work was supported by the Institute of Bioengineering and
Nanotechnology (Biomedical Research Council, Agency for Science,
Technology and Research, Singapore).
N,N-Diethyl-1,3-diphenylprop-2-yn-1-amine (4B)18
1H NMR (400 MHz, CDCl3): d = 7.68–7.10 (m, 2H, Ar-H), 7.50–
7.53 (m, 2H, Ar-H), 7.28–7.38 (m, 6H, Ar-H), 5.06 (s, 1H, CH),
2.60–2.69 (m, 2H, CH2), 2.51–2.59 (m, 2H, CH2), 1.09 (t, J = 7.2 Hz,
6H, CH3); 13C NMR (100 MHz, CDCl3): d = 139.85, 131.77, 128.34,
128.27, 128.27, 128.01, 127.22, 123.36, 87.40, 86.07, 56.92, 44.52,
13.56; GC–MS: m/z: 263.
Supplementary data
Supplementary data (analytical data and spectra (1H and 13C
NMR) for all products and HRMS for new products) associated with
this article can be found, in the online version, at doi:10.1016/
3-(4-Chlorophenyl)-N,N-diethyl-1-phenylprop-2-yn-1-amine
(7B)
References and notes
1H NMR (400 MHz, CDCl3): d = 7.66 (d, J = 7.6 Hz, 2H, Ar-H), 7.43
(d, J = 7.6 Hz, 2H, Ar-H), 7.36 (t, J = 7.6 Hz, 2H, Ar-H), 7.27–7.31
1. Yoshida, Y.; Murakami, K.; Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2010, 132,
8878–8879.